Market Place
Sourcing Support
Enlivex Doses First 10 Patients in Allocetra Knee OA Trial
12 Nov 2024 //
GLOBENEWSWIRE
CMS Establishes Additional Payment for iovera in Outpatient
04 Nov 2024 //
GLOBENEWSWIRE
Pacira Gets New J-Code For Exparel Starting January 2025
03 Oct 2024 //
GLOBENEWSWIRE
Heron Announces FDA Approval for Zynrelef
25 Sep 2024 //
PR NEWSWIRE
Pacira BioSciences Reports Inducement Grants Under Nasdaq
09 Sep 2024 //
GLOBENEWSWIRE
ZYNRELEF Included As Qualifying Product Under Proposed Non-Opioid Policy
15 Jul 2024 //
PR NEWSWIRE
CMS Proposes New EXPAREL Reimbursement For Outpatient Surgery In 2025
10 Jul 2024 //
GLOBENEWSWIRE
Heron`s ZYNRELEF Vial Access Needle Application Accepted
02 Jul 2024 //
PR NEWSWIRE
Hengrui Pharma`s Generic Bupivacaine liposome Receives Approval in US
02 Jul 2024 //
FDA
Heron Submits PAS For ZYNRELEF Vial Access Needle To FDA
31 May 2024 //
PR NEWSWIRE
Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
30 Apr 2024 //
BUSINESSWIRE
Heron Therapeutics Announces Partnership with CrossLink Life Sciences
07 Jan 2024 //
PR NEWSWIRE
Heron Therapeutics Announces Filing of an Efficacy Supplement for ZYNRELEF
29 Dec 2022 //
PR NEWSWIRE
Innocoll and DURECT Announce U.S. launch of POSIMIR®
26 Sep 2022 //
PRNEWSWIRE
Enforcement Report - Week of August 24, 2022
24 Aug 2022 //
FDA
FDA Confirms Paragraph IV Patent Litigation for Bupivacaine Liposome
13 Jun 2022 //
FDA
Pacira Biosciences Reports Preliminary Revenues Of $158.4M for Q1 2022
12 Apr 2022 //
PRESS RELEASE
FDA approves expansion for ZYNRELEF
10 Dec 2021 //
PHARMAFILE
Heron Announces FDA Approval of Significant Indication Expansion for ZYNRELEF
09 Dec 2021 //
PRNEWSWIRE
Pacira buys Flexion for $450M to boost pain offerings
12 Oct 2021 //
FIERCEPHARMA
Pacira BioSciences Signs Exparel Distribution Agreement With Eurofarma
22 Jun 2021 //
GLOBENEWSWIRE
Heron`s Zynrelef could hit blockbuster heights, analysts predict
15 May 2021 //
FIERCE PHARMA
Pacira BioSciences Seeks Court Injunction to Protect Clinical Integrity EXPAREL
15 Apr 2021 //
PRESS RELEASE
Innocoll nnounces First Patients In Ph3 Trials for Label Expansion of Xaracoll®
14 Apr 2021 //
BIOSPACE
DURECT Announces U.S. FDA Approval of POSIMIR® For Post-Surgical Pain Reduction
02 Feb 2021 //
BIOSPACE
PACIRA RECEIVES EUROPEAN COMMISSION APPROVAL FOR EXPAREL®
18 Nov 2020 //
PRESS RELEASE
Innocoll Announces Commercial Launch of XARACOLL® (bupivacaine HCI)
29 Oct 2020 //
PRNEWSWIRE
EMA Recommends Seven Medicines for Approval
18 Sep 2020 //
PHARMATECH
Pacira Receives Positive CHMP Opinion for EXPAREL® for Postsurgical Pain
18 Sep 2020 //
GLOBENEWSWIRE
Pacira BioSciences Announces Settlement of Government Investigation
29 Jul 2020 //
GLOBENEWSWIRE
EMA: Thumbs up for 11, down for 2 new medicines
25 Jul 2020 //
RAPS
Heron Announces Publication of Results from Study 209 2b Study of HTX-011
04 Jun 2020 //
PRNEWSWIRE
Heron`s Groundhog Day; Vifor forms JV with Fresenius Kabi in China
21 Feb 2020 //
ENDPTS
Enforcement Report - Week of December 11, 2019
11 Dec 2019 //
FDA
Pacira completes patient enrollment in ph 3 of Exparel
20 Sep 2019 //
PHARMABIZ
Aratana Therapeutics Granted FDA Approval of NOCITA®
13 Jun 2019 //
PR NEWSWIRE
Aratana Therapeutics to be Acquired by Elanco Animal Health
26 Apr 2019 //
BIOSPACE
Enforcement Report - Week of April 24, 2019
24 Apr 2019 //
FDA
DURECT Announces Plans to Submit to FDA a Full Response to the POSIMIR®
27 Feb 2019 //
BIOSPACE
FDA Warns Against Using Implanted Pumps With Unapproved Drugs
14 Nov 2018 //
RAPS
Liquidia files for IPO to challenge United Therapeutics in PAH
03 Jul 2018 //
FIERCE BIOTECH
NobleStitch™ EL Continues Expansion Through EU With Sales Launch In NL
01 Jun 2018 //
PR NEWSWIRE
DURECT Announces Amendment to Licensing Agreement, Sandoz Related to POSIMIR®
09 May 2018 //
PR NEWSWIRE
Novartis, Durect amend $293M painkiller deal after phase 3 loss
09 May 2018 //
FIERCE BIOTECH
DURECT Announces FDA Advisory Committee Meeting for REMOXY® ER
20 Mar 2018 //
PRNEWSWIRE
FDA advisers reject new use for Pacira nerve block
17 Feb 2018 //
PHARMAPHORUM
SCA Pharmaceuticals Issues Voluntary Nationwide Recall of Specific Products
21 Oct 2017 //
FDA
Enforcement Report - Week of August 2, 2017
02 Aug 2017 //
FDA
Innocoll Receives Refusal to File Letter from USFDA for Xaracoll NDA
29 Dec 2016 //
GLOBENEWSWIRE
Moberg Pharma Receives European Patent for BUPI to Treat Oral Mucositis
22 Oct 2016 //
PHARMABIZ
Aratana Therapeutics Announces Launch of NOCITA®
05 Oct 2016 //
PR NEWSWIRE
Fertility drugs drive healthcare growth at Merck KGaA
04 Aug 2016 //
PMLIVE
Claris Life gets USFDA nod for generic anesthetic injection
26 Jul 2016 //
ECONOMIC TIMES
